Biopharmacetiucal Approval Trends in 2009 - Biotech approvals were up last year. Is it a sign of a new trend? - BioPharm International

ADVERTISEMENT

Biopharmacetiucal Approval Trends in 2009
Biotech approvals were up last year. Is it a sign of a new trend?


BioPharm International
Volume 23, Issue 10

REFERENCES

1. The future of the biological market. Business insights report. 2010 Mar. Available from: http://www.globalbusinessinsights.com/

2. Carlson B. Biosimilar market fails to meet projections. Gen Eng Biotechnol News. 2009;29:43–5.

3. US Food and Drug Administration. CDER drug and biologic calendar year approvals. 2009 Dec 31. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/PriorityNDAandBLAApprovals/UCM090995.pdf 4.

4. European Medicines Agency. Available from: http://www.ema.europa.eu/ema

5. Walsh G. Biopharmaceuticals: approvals and approval trends in 2008. Biopharm Int. 2009;22(10):68–77.

6. Walsh G. Biopharmaceuticals: approval trends in 2007. BioPharm Int. 2008;21(10):52–65.

7. Walsh G. Biopharmaceuticals: approval trends in 2006. BioPharm Int. 2007;20(10):56–67.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here